tiprankstipranks
Trending News
More News >
Bionano Genomics (BNGO)
NASDAQ:BNGO
US Market

BioNano Genomics (BNGO) Income Statement

Compare
9,215 Followers

BioNano Genomics Income Statement

Last quarter (Q3 2025), BioNano Genomics's total revenue was $7.37M, a decrease of -9.75% from the same quarter last year. In Q3, BioNano Genomics's net income was $-8.50M. See BioNano Genomics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 30.78M$ 36.12M$ 27.80M$ 17.98M$ 8.50M
Gross Profit
$ 380.00K$ 9.57M$ 5.95M$ 3.87M$ 2.77M
Operating Expenses
$ 104.36M$ 224.81M$ 137.64M$ 80.97M$ 41.32M
Depreciation and Amortization
$ 14.23M$ 13.71M$ 10.10M$ 3.37M$ 1.48M
EBITDA
$ -97.47M$ -213.60M$ -120.31M$ -73.86M$ -35.57M
Operating Income
$ -103.98M$ -215.25M$ -131.70M$ -77.10M$ -38.55M
Other Income/Expenses
$ -8.00M$ -17.19M$ 986.00K$ -1.05M$ -2.53M
Pretax Income
$ -111.98M$ -232.43M$ -130.71M$ -78.15M$ -41.08M
Net Income
$ -112.02M$ -232.49M$ -132.60M$ -72.44M$ -41.11M
Per Share Metrics
Basic EPS
$ -88.13$ -24.51K$ -16.51K$ -9.42K$ -14.19K
Diluted EPS
$ -88.13$ -24.52K$ -16.51K$ -9.42K$ -14.19K
Weighted Average Shares Outstanding
1.90M 580.38K---
Weighted Average Shares Outstanding (Diluted)
1.90M----
Currency in USD

BioNano Genomics Earnings and Revenue History